Sapien Heart Valve Gets FDA Panel Nod For High-Risk Surgical Patients
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences’ first-to-market transcatheter valve is safe and effective, and its benefits outweigh its risks in an expanded patient population, an FDA advisory panel says.